GlobeStar Therapeutics Corporation reported earnings results for the full year ended September 30, 2023. For the full year, the company reported net loss was USD 1.95 million compared to USD 1.49 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0009 USD | -.--% | +20.00% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 512K | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.15% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- GSTC Stock
- SOAN Stock
- News ANGIOSOMA
- GlobeStar Therapeutics Corporation Reports Earnings Results for the Full Year Ended September 30, 2023